Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis
The combination of intermittent fasting and chemotherapy can improve the response to treatment. Here, the authors show that SIRT7 activation is required to inactivate Akt during intermittent fasting and that the combination of intermittent fasting and inhibitors that block the Erk pathway can improv...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b558c32cb2f94905887f6a978bd50b73 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b558c32cb2f94905887f6a978bd50b73 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b558c32cb2f94905887f6a978bd50b732021-12-02T19:02:36ZCombined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis10.1038/s41467-021-25274-32041-1723https://doaj.org/article/b558c32cb2f94905887f6a978bd50b732021-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25274-3https://doaj.org/toc/2041-1723The combination of intermittent fasting and chemotherapy can improve the response to treatment. Here, the authors show that SIRT7 activation is required to inactivate Akt during intermittent fasting and that the combination of intermittent fasting and inhibitors that block the Erk pathway can improve efficacy of treatment.Xiaolong TangGuo LiLei ShiFengting SuMinxian QianZuojun LiuYuan MengShimin SunJi LiBaohua LiuNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-18 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Xiaolong Tang Guo Li Lei Shi Fengting Su Minxian Qian Zuojun Liu Yuan Meng Shimin Sun Ji Li Baohua Liu Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis |
description |
The combination of intermittent fasting and chemotherapy can improve the response to treatment. Here, the authors show that SIRT7 activation is required to inactivate Akt during intermittent fasting and that the combination of intermittent fasting and inhibitors that block the Erk pathway can improve efficacy of treatment. |
format |
article |
author |
Xiaolong Tang Guo Li Lei Shi Fengting Su Minxian Qian Zuojun Liu Yuan Meng Shimin Sun Ji Li Baohua Liu |
author_facet |
Xiaolong Tang Guo Li Lei Shi Fengting Su Minxian Qian Zuojun Liu Yuan Meng Shimin Sun Ji Li Baohua Liu |
author_sort |
Xiaolong Tang |
title |
Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis |
title_short |
Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis |
title_full |
Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis |
title_fullStr |
Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis |
title_full_unstemmed |
Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis |
title_sort |
combined intermittent fasting and erk inhibition enhance the anti-tumor effects of chemotherapy via the gsk3β-sirt7 axis |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/b558c32cb2f94905887f6a978bd50b73 |
work_keys_str_mv |
AT xiaolongtang combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis AT guoli combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis AT leishi combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis AT fengtingsu combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis AT minxianqian combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis AT zuojunliu combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis AT yuanmeng combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis AT shiminsun combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis AT jili combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis AT baohualiu combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis |
_version_ |
1718377232309682176 |